Omada Health Executive Stock Sale Disclosed to SEC
1 report, 1 independent
Updated Sep 23
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Omada Health disclosed a transaction via an SEC filing on September 23, 2026. The filing detailed that Wei-Li Shao, the company President, sold 9,418 shares on August 12, 2026. The sale was executed under a Rule 10b5-1 trading plan adopted by Shao on March 13, 2026.
From fool.com
Why it matters
The filing provides transparency regarding insider trading activity, showing that the President of Omada Health continues to hold over 307,000 shares following the transaction. Omada Health reported trailing-twelve-month revenue of $309.8 million and net income of $4.3 million.
From fool.com
Who's involved
- SECRegulatory body that received the disclosure of the executive stock sale.
Keep exploring
The entities involved
-
SEC
Slovak company
Related events
- Universal Insurance disclosed transactions via a required legal filing with the SEC.
- Oscar Health filed a transaction disclosure with the U.S. Securities and Exchange Commission on August 31, 2026.
- Director Matthew Miller filed transaction details with the SEC on September 14, 2026.
- Visteon filed transaction details with the SEC and traded on the Nasdaq stock exchange on June 6, 2026.
- LifeStance Health Group filed disclosures with the SEC regarding stock purchases on September 6, 2026.